Commonwealth Equity Services
CLVS

Commonwealth Equity Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Commonwealth Equity Services’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,918
Closed -$221K – 2833
2019
Q1 		$221K Buy
+8,918
New +$224K ﹤0.01% 2392
2017
Q4 		– Sell
-2,903
Closed -$239K – 2730
2017
Q3 		$239K Buy
+2,903
New +$230K ﹤0.01% 2132

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Commonwealth Equity Services's CLVS Position: Q2 2019 in Review

Commonwealth Equity Services sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 8,918 shares — an estimated $221K sold.

Commonwealth Equity Services first reported a position in CLVS in Q3 2017 and held it in 2 quarters. The position peaked at $239K in Q3 2017. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

  • Commonwealth Equity Services reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
  • Commonwealth Equity Services sold 8,918 Clovis Oncology, Inc. shares in Q2 2019, an estimated $221K.
  • Commonwealth Equity Services first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 2 quarters.
  • Commonwealth Equity Services's Clovis Oncology, Inc. position peaked at $239K in Q3 2017.
  • 167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on Commonwealth Equity Services's 13F filing for Q2 2019, filed 19 Jul 2019.